Rejnowicz E, Batchelor M, Leen E, Ahangar M, Burgess S, Richards M
Biochem J. 2024; 481(21):1535-1556.
PMID: 39370942
PMC: 11555651.
DOI: 10.1042/BCJ20240248.
Vidal R, Leen E, Herold S, Muller M, Fleischhauer D, Schulein-Volk C
Elife. 2024; 13.
PMID: 39177021
PMC: 11343564.
DOI: 10.7554/eLife.94407.
Curti L, Rohban S, Bianchi N, Croci O, Andronache A, Barozzi S
Nat Commun. 2024; 15(1):7100.
PMID: 39155303
PMC: 11330984.
DOI: 10.1038/s41467-024-51229-5.
Cantarella S, Vezzoli M, Carnevali D, Morselli M, Zemke N, Montanini B
Nucleic Acids Res. 2024; 52(16):9481-9500.
PMID: 39011896
PMC: 11381368.
DOI: 10.1093/nar/gkae615.
Krenz B, Lee J, Kannan T, Eilers M
Mol Oncol. 2024; 18(10):2338-2355.
PMID: 38957016
PMC: 11459038.
DOI: 10.1002/1878-0261.13695.
Targeting MYC effector functions in pancreatic cancer by inhibiting the ATPase RUVBL1/2.
Vogt M, Dudvarski Stankovic N, Cruz Garcia Y, Hofstetter J, Schneider K, Kuybu F
Gut. 2024; 73(9):1509-1528.
PMID: 38821858
PMC: 11347226.
DOI: 10.1136/gutjnl-2023-331519.
The choreography of chromatin in RNA polymerase III regulation.
van Breugel M, Gerber A, van Leeuwen F
Biochem Soc Trans. 2024; 52(3):1173-1189.
PMID: 38666598
PMC: 11346459.
DOI: 10.1042/BST20230770.
MYCN drives oncogenesis by cooperating with the histone methyltransferase G9a and the WDR5 adaptor to orchestrate global gene transcription.
Liu Z, Zhang X, Xu M, Hong J, Ciardiello A, Lei H
PLoS Biol. 2024; 22(3):e3002240.
PMID: 38547242
PMC: 11003700.
DOI: 10.1371/journal.pbio.3002240.
PAF1c links S-phase progression to immune evasion and MYC function in pancreatic carcinoma.
Gaballa A, Gebhardt-Wolf A, Krenz B, Mattavelli G, John M, Cossa G
Nat Commun. 2024; 15(1):1446.
PMID: 38365788
PMC: 10873513.
DOI: 10.1038/s41467-024-45760-8.
Characterization of Tau95 led to the identification of a four-subunit TFIIIC complex in trypanosomatid parasites.
Mondragon-Rosas F, Florencio-Martinez L, Villa-Delavequia G, Manning-Cela R, Carrero J, Nepomuceno-Mejia T
Appl Microbiol Biotechnol. 2024; 108(1):109.
PMID: 38204130
PMC: 10781861.
DOI: 10.1007/s00253-023-12903-8.
Spt5 interacts genetically with Myc and is limiting for brain tumor growth in .
Hofstetter J, Ogunleye A, Kutschke A, Buchholz L, Wolf E, Raabe T
Life Sci Alliance. 2023; 7(1).
PMID: 37935464
PMC: 10629571.
DOI: 10.26508/lsa.202302130.
To Break or Not to Break: The Role of TOP2B in Transcription.
Cowell I, Casement J, Austin C
Int J Mol Sci. 2023; 24(19).
PMID: 37834253
PMC: 10573011.
DOI: 10.3390/ijms241914806.
The Conserved Chromatin Remodeler SMARCAD1 Interacts with TFIIIC and Architectural Proteins in Human and Mouse.
Sachs P, Bergmaier P, Treutwein K, Mermoud J
Genes (Basel). 2023; 14(9).
PMID: 37761933
PMC: 10530723.
DOI: 10.3390/genes14091793.
Structural insights into human TFIIIC promoter recognition.
Seifert-Davila W, Girbig M, Hauptmann L, Hoffmann T, Eustermann S, Muller C
Sci Adv. 2023; 9(27):eadh2019.
PMID: 37418517
PMC: 11811891.
DOI: 10.1126/sciadv.adh2019.
When Just One Phosphate Is One Too Many: The Multifaceted Interplay between Myc and Kinases.
Boi D, Rubini E, Breccia S, Guarguaglini G, Paiardini A
Int J Mol Sci. 2023; 24(5).
PMID: 36902175
PMC: 10003727.
DOI: 10.3390/ijms24054746.
Crystal structure of a covalently linked Aurora-A-MYCN complex.
Diebold M, Schonemann L, Eilers M, Sotriffer C, Schindelin H
Acta Crystallogr D Struct Biol. 2023; 79(Pt 1):1-9.
PMID: 36601802
PMC: 9815099.
DOI: 10.1107/S2059798322011433.
Molecular Profile Changes in Patients with Castrate-Resistant Prostate Cancer Pre- and Post-Abiraterone/Prednisone Treatment.
Sicotte H, Kalari K, Qin S, Dehm S, Bhargava V, Gormley M
Mol Cancer Res. 2022; 20(12):1739-1750.
PMID: 36135372
PMC: 9716248.
DOI: 10.1158/1541-7786.MCR-22-0099.
Regulating the regulator: a survey of mechanisms from transcription to translation controlling expression of mammalian cell cycle kinase Aurora A.
Cacioppo R, Lindon C
Open Biol. 2022; 12(9):220134.
PMID: 36067794
PMC: 9448500.
DOI: 10.1098/rsob.220134.
MYC: a complex problem.
Das S, Lewis B, Levens D
Trends Cell Biol. 2022; 33(3):235-246.
PMID: 35963793
PMC: 9911561.
DOI: 10.1016/j.tcb.2022.07.006.
Advancing therapy for neuroblastoma.
Qiu B, Matthay K
Nat Rev Clin Oncol. 2022; 19(8):515-533.
PMID: 35614230
DOI: 10.1038/s41571-022-00643-z.